Abstract:We read with interest the article by Luttikhold et al. [11] about the treatment of esophageal perforations with endoscopic vacuum therapy (EVT). The authors described a rate of 70% for successful defect closure with EVT alone and 89% when used in addition to other endoscopic treatments. The majority of the included cases (n=16/27) had an iatrogenic perforation of unclear etiology; we kindly ask the authors to clarify this point and provide more details regarding the "scenario" where EVT might be indicated. The study also reported that the treatment was started immediately after diagnosis for cases of iatrogenic perforation, obtaining 100% clinical success, confirming the remark: "the earlier, the better." Other factors involved in a successful treatment were: etiology, size and location of the perforation, presence or absence of a communicating collection, and age and co-morbidities of the patient. For these reasons, in the authors' experience, the Boerhaave syndromes had the worst outcomes: more time required to start the treatment, higher mortality due to the etiology, larger perforation size, and the presence of empyema. As underlined by Mandarino et al. [22], most of the patients (78%) received an intraluminal sponge alone to treat small (<10mm) and intermediate (10–19mm) perforations without the presence of collections and in non-anastomotic leakage. In these situations, the sponge aspirates mainly saliva and gastric juice; the same result could be achieved with widely available and cheaper gastric tubes. Also, there is a risk of sponge dislodgement resulting in delayed treatment. Furthermore, the use of endoscopic clips (both over-the-scope and through-the-scope clips) is the first-line option for primary closure of small and intermediate esophageal perforations [33]. We agree with the authors that every single patient and situation should be carefully evaluated, and the best-tailored approach should be chosen. We thank the authors for sharing their extensive experience in using EVT. Article published online: 29 May 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

S4057 Endoscopic Vacuum Therapy for the Management of Atrial Fibrillation-Induced Esophageal Perforation

PV isolation guided by esophageal visualization with a tailored ablation strategy for the avoidance of esophageal thermal injury: a randomized trial

An abnormal left ventricular-atrial perforation after radiofrequency catheter ablation: a case report

A novel treatment for esophageal lesions following atrial fibrillation ablation

Prevention and Treatment of Atrioesophageal Fistula Related to Catheter Ablation for Atrial Fibrillation

Endoscopic Ultrasound for the Evaluation of Esophageal Injury After Catheter Ablation for Atrial Fibrillation

Endovascular Stent-Graft Treatment In Aortoesophageal Fistula Caused By Foreign Bodies

Atrioesophageal fistula post atrial fibrillation ablation: A multicenter study from China.

Endoscopic vacuum therapy for esophageal perforations: size and etiology of the defect need to be considered

Characteristics Of Atrial Fibrillation Patients Suffering Esophageal Injury Caused By Ablation For Atrial Fibrillation

Prevention of left atrium esophagus fistula: Appraisal of existing technologies and strategies

Endoluminal Vacuum Therapy Using a New "Fistula Sponge" in Treating Defects of the Upper Gastrointestinal Tract-A Comparative, Retrospective Cohort Study

S3408 Esophageal Thermal Injury After Atrial Fibrillation Ablation

Peri-Operative Anesthetic Management of Left Atrial-Esophageal Fistula

Vacuum-stent: A combination of endoscopic vacuum therapy and an intraluminal stent for treatment of esophageal transmural defects

S3246 Esophageal Management of an Aortoesophageal Fistula

Results of endoscopic vacuum-assisted closure device for treatment of upper GI leaks

Outcome of endoscopic vacuum therapy for duodenal perforation

Endoluminal Vacuum Therapy as a Salvage Procedure for Difficult Anastomotic Leak Post Roux-en-Y Gastric Bypass

Relationship of the esophagus and aorta to the left atrium and pulmonary veins: implications for catheter ablation of atrial fibrillation

Emerging Technologies for Pulmonary Vein Isolation